Principal Investigator, Michael Demetriou, MD, PhD (IMAGE)

University of California - Irvine

Principal Investigator, Michael Demetriou, MD, PhD

Caption

Principal investigator, Michael Demetriou, MD, PhD, a professor of neurology, microbiology and molecular genetics and member of the NCI-designated Chao Comprehensive Cancer Center at UCI, along with his post-doctoral fellow, Raymond Zhou, PhD, have invented a novel technology called Glycan dependent T cell Recruiter (GlyTR - pronounced 'glitter'), new class of cancer killing immunotherapeutics with the potential to treat highly diverse types of cancer, from leukemia to breast cancer.

Credit

University of California, Irvine

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.